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Mitochondria are the major reactive oxygen species (ROS) – generating sites in mammalian cells. Blockade of 
complexes in the electron transport chain (ETC) increases the leakage of single electrons to O2 and therefore in-
creases ROS levels. Complexes I and III have been reported to be the major ROS-generating sites in mitochondria. 
In this study, using mouse hippocampal HT22 cells as in vitro model, we monitored the change of intracellular 
ROS level in response to the blockade of ETC at different complex, and measured changes of gene expression of 
antioxidant enzymes and phase II enzymes, also evaluated potential protective effect of selenium (Se) supple-
mentation to the cells under this oxidative stress. In summary, our results showed that complex I was the major 
ROS-generating site in HT22 cells. Complex I blockade upregulated the mRNA levels of glutamylcysteine syn-
thetase heavy and light chains, glutathione-S-transferases omega1 and alpha 2, hemoxygenase 1, thioredoxin 
reductase 1, and selenoprotein H. Unexpectedly, the expression of the enzymes that directly scavenge ROS de-
creased, including superoxide dismutases 1 and 2, glutathione peroxidase 1, and catalase. Se supplementation 
increased glutathione levels and glutathione peroxidase activity, indicating a potential protective role in oxida-
tive stress caused by ETC blockade. 
Key words: electron transport chain, complex I, rotenone, ROS, antioxidant 
1.  Introduction 
Over 90% of tissue respiration is due to oxygen 
consumption by mitochondria [1]. Superoxide is gen-
erated by one electron reduction of O2 by the electron 
transport chain (ETC), leading to formation of other 
reactive oxygen species (ROS). The percentage of O2 
that is converted to superoxide in mitochondria has 
been reported ranging from 0.15 to 2% [2]. Production 
of ROS from the ETC is generally considered as the 
major continuous source of cellular oxidative stress, 
and as a major participant in pathophysiological 
processes, particularly aging and its associated de-
generative diseases [3, 4].  
The ETC in eukaryotic mitochondria consists of 
four complexes, transferring electrons from NADH to 
O2. When the ETC is blocked by an inhibitor, the re-
duction state of electron carriers increases on the sub-
strate side of the inhibitor, while those on the oxygen 
side become more oxidized. Reduced complexes in the 
ETC have the ability to produce superoxide [1].  
Mitochondrial complex I accepts electrons from 
NADH and passes them through flavin and 
iron-sulfur centers to ubiquinone [5]. Many structur-
ally diverse hydrophobic compounds have been de-
scribed to inhibit complex I by interfering with 
ubiquinone reduction, such as piericidin A (A type), 
rotenone (B type), and capsaicin (C type) [6]. Complex 
II uses succinate as substrate and provides electrons to 
ubiquinone. Malonate (MA) inhibits succinate dehy-
drogenase [7]. Complex III accepts electrons from 
ubiquinone and passes them on to cytochrome c [8]. It 
has two redox centers, known as Qo and Qi that can be 
inhibited by stigmatellin (ST) and Antimycin A (AA), 
respectively [8, 9]. Both complexes I and III have been 
reported to be the major ROS-generating sites in ETC 
[10-13]. 
 
Inhibition of the activity of complex I in the ETC, 
e.g. upon exposure to the pesticide rotenone (Rot), has 
been identified as one of the major pro-oxidative fac-
tors causing Parkinson’s disease (PD) [14-16]. Animal 
studies showed that chronic exposure to Rot repro-
d u c e s  f e a t u r e s  o f  P a r k i n s o n i s m  i n  r a t s  [ 1 7 ,  1 8 ] ,  a n d  
selenium (Se), a trace element possessing antioxidant 
properties, prevented or slowed down neuronal injury 
in mouse PD models [19, 20]. 
 
  In this study, we treated murine hippocampal 
HT22 cells with Rot, MA, AA/ST to block complexes I, 
II and III, respectively. We measured the changes of 
intracellular superoxide level induced by the treat-
ments. We also monitored the change of gene expres-
sion of antioxidant and phase II enzymes in response 
to Rot treatment and investigated the potential protec-
tive effect of Se supplementation in this oxidative 
stress.  Int. J. Biol. Sci. 2007, 3 
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2.  Materials and Methods 
Cells 
HT22 cells were maintained in Dulbecco’s Modi-
fied Eagle Medium with 10% fetal bovine serum, 15 
µg/ml gentamicin, 50 µg/ml ampicillin, and 4 mM 
L-glutamine supplement, in 5% CO2 at 37°C, 50 % 
relative humidity. 
Chemicals 
Dihydroethidium (hydroethidine, HEt) was 
purchased from Molecular Probes (Carlsbad, CA). 
GSH/GSSG-412 TM assay kit was purchased from Oxis 
(Foster City, CA). RNeasy Mini Kit was purchased 
from Qiagen (Valencia, CA). SuperScript III 
First-Strand synthesis system and Platinum SYBR 
Green qPCR SuperMix-UDG kit were purchased from 
Invitrogen (Carlsbad, CA). All other chemicals were 
purchased from Sigma (St. Louis, MO). 
Instruments  
A Beckman Coulter Epics XL-MCL flow cytome-
ter (Fullerton, CA) was used to measure the mean 
fluorescence intensity of the oxidized HEt to indicate 
the intracellular ROS level, a DU7500 Spectropho-
tometer (Beckman, Fullerton, CA) was used for total 
glutathione (GSH) and glutathione peroxidase (GPx) 
activity assays, and a LightCycler 2.0 real-time PCR 
machine (Roche, Indianapolis, IN) was used for the 
relative quantification on the mRNA levels. 
Cell culture, treatment and harvesting 
HT22 cells were seeded at a density of 4.5e4 cells 
/cm2 in multi-well cell culture plates (Costar, Be-
thesda, MA) 20 h before treatments. To monitor the 
superoxide-inducing effect of different chemicals, cells 
were incubated in culture media containing Rot, MA, 
AA or ST at desired concentrations for 30 min. The 
same amount of dimethyl sulfoxide (DMSO, solvent 
control) was applied in the culture media of the control 
cells.  
To study the time-dependent change of intracel-
lular superoxide level after withdrawal of the ETC 
inhibitors, the cells were allowed to recover in normal 
medium for 0.5 – 8 hours after treatment with 
ETC-inhibitors for 30 min and washed once with warm 
PBS. DMSO-treated cells were used as controls. Prop-
erly treated cells were then harvested and subjected to 
flow cytometric assay. 
For Se supplementation, the cells were seeded at 
a density of 4.5e4 cells /cm2 in 100 mm cell culture 
dishes, and incubated with 100 nM sodium selenite for 
24 h. Cells were then subjected to 1.25 μM Rot treat-
ment (a concentration that causes decrease in total in-
tracellular GSH level in HT22 cells) for 30 min, washed 
twice with cold PBS, collected and centrifuged at 5000 
x g for 5 min. The pellet was sonicated in cold PBS. The 
cell lysate was centrifuged for 10 min at 10,000 x g, the 
supernatant was collected for GSH and GPx assays. 
For gene expression quantification, the cells were 
seeded at a density of 4.5e4 cells /cm2 in 100 mm cell 
culture dishes and incubated with culture media con-
taining 0.5 µM Rot for 16 h, with cells treated with 
equal amount of DMSO as control. The cells were also 
treated with 0.5 µM of Rot for 0, 0.5, 4, and 16 h to 
monitor the onset time in gene regulation. RNA was 
harvested from the cells for real-time PCR quantifica-
tion of the expression of genes of interest. 
Flow Cytometric assay 
After desired treatments, the cells were incubated 
with Hank’s Balanced Salt Solution containing 5 µM of 
HEt for 30 min, allowing the dye to enter into the cells 
and get oxidized by superoxide. Then the cell culture 
plates were placed on ice, cells were washed with 
ice-cold PBS once, trypsinized, and re-suspend in se-
rum-free culture medium. Samples were kept on ice 
and protected from light before the flow cytometric 
assay. Five thousand cells were counted for each mean 
fluorescent intensity value. 
Quantification of gene expression by real-time PCR 
The expression levels of mRNAs encoding ROS 
scavenging enzymes, phase II enzymes and some se-
lenoproteins were quantified using real-time PCR in 
the Rot-treated HT22 cells, using DMSO-treat cells as 
control. The enzymes directly scavenging ROS in-
cluded glutathione peroxidase 1 (GPx1, also a se-
lenoenzyme), catalase (Cat), superoxide dismutases 1 
and 2 (SOD1, SOD2); phase II enzymes included glu-
tamylcysteine synthetase heavy chain and light chain 
(GCS-HC, GCS-LC); glutathione S-transferase omega 1 
and alpha 2 (GSTo1, GSTa2), and heme oxygenase-1 
(HO-1); selenoproteins thioredoxin reductases 1 (TR1), 
and selenoprotein H (SelH) were also investigated. 
Table 1. Primers used for real-time PCR for specific cDNA 
amplification.  
Gene  Sequence of primer 
GAPDH forward   5’-TGACATCAAGAAGGTGGTGAAGC-3’ 
GAPDH reverse  5’-CCCTGTTGCTGTAGCCGTATTC-3’ 
HPRT1 forward  5’-TCCTCCTCAGACCGCTTTT-3’ 
HPRT1 reverse  5’-CCTGGTTCATCATCGCTAATC-3’ 
SelH forward  5’-GGAAGAAAGCGTAAGGCGGG-3’ 
SelH reverse  5’-GGTTTGGACGGGTTCACTTGC-3’ 
GPx1 forward  5’-ACAGTCCACCGTGTATGCCTTC-3’ 
GPx1 reverse  5’-CTCTTCATTCTTGCCATTCTCCTG-3’ 
TR1 forward  5’-CCTATGTGGCCTTGGAATGTGC-3’ 
TR1 reverse  5’-ATGGTCTCCTCGCTGTTTGTGG-3’ 
SOD1 forward  5’-CAGGACCTCATTTTAATCCTCAC-3’ 
SOD1 reverse  5’-CCCAGGTCTCCAACATGC-3’ 
SOD2 forward  5’-CTGGACAAACCTGAGCCCTA-3’ 
SOD2 reverse  5’-TGATAGCCTCCAGCAACTCTC-3’ 
Cat forward  5’-CAGCGACCAGATGAAGCA-3’ 
Cat reverse  5’-CTCCGGTGGTCAGGACAT-3’ 
GCS-HC forward  5’-ATGATAGAACACGGGAGGAGAG-3’ 
GCS-HC reverse  5’-TGATCCTAAAGCGATTGTTCTTC-3’ 
GCS-LC forward  5’-TGACTCACAATGACCCGAAA-3’ 
GCS-LC reverse  5’-GATGCTTTCTTGAAGAGCTTCCT-3’ 
GSTo1 forward  5’-CAGCGATGTCGGGAGAAT-3’ 
GSTo1 reverse  5’-GGCAGAACCTCATGCTGTAGA-3’ 
GSTa2 forward  5’-TCTGACCCCTTTCCCTCTG-3’ 
GSTa2 reverse  5’-GCTGCCAGGATGTAGGAACT-3’ 
HO-1 forward  5’-GGTCAGGTGTCCAGAGAAGG-3’ 
HO-1 reverse  5’-CTTCCAGGGCCGTGTAGATA-3’ 
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Total RNA was harvested using RNeasy mini kit. 
cDNA were synthesized from the RNA extracts using 
SuperScript III First-Strand synthesis system (Invitro-
gen). The specific primers used for real-time PCR on 
the housekeeping genes (GAPDH, glyceralde-
hyde-3-phosphate dehydrogenase; HPRT1, hypoxan-
thine phosphoribosyltransferase 1) and target genes 
are listed in Table 1. All PCR reactions were performed 
in 10 μl reaction volume using Platinum SYBR Green 
qPCR SuperMix-UDG kit (Invitrogen). The amplifica-
tion and detection were carried out using a LightCy-
cler 2.0 real-time PCR machine (Roche). 
GSH measurement 
The total intracellular GSH assay was carried out 
using the GSH/GSSG-412 TM (OXIS) assay kit follow-
ing the manufacturer’s instructions. 
GPx activity assay   
The assay was based on the classical principle [21] 
with optimization to the HT22 cell lysate. The peroxide 
used in this study was t-butyl hydroperoxide (0.32 
mM), the concentration of GSH was 1.88 mM, and the 
pH of the assay was 7.6. The unit of GPx activity was 
defined as 1mU = 1 nmole NADPH oxidized per min. 
Statistical analysis 
GraphPad Prism 4 software was used for un-
paired two-tailed t-test or two-way ANOVA analysis. 
P ≤ 0.05 was considered statistically significant. * in-
dicates 0.01< P ≤ 0.05; ** indicates 0.001< P ≤ 0.01; *** 
indicates P ≤ 0.001. 
3.  Results 
Rotenone treatment induced the highest intracel-
lular superoxide level  
Different concentrations of ETC-inhibitors were 
used to treat HT22 cells. Specifically they were: Rot 0 – 
2.5 µM, MA 0 – 15 mM, AA 0 - 40 µM, and ST 0 – 30 
µM. The dose-response curves are summarized in 
Figure 1. Rot treatment most efficiently increased the 
intracellular superoxide generation to 300% of the 
control level, followed by the treatments of MA 
(180%), ST (150%), and AA (130%). 
Change of superoxide overproduction after with-
drawal of ETC-inhibitors 
 After 30 min treatment with Rot, MA, AA, or ST, 
the cells were allowed to recover in normal medium as 
described above. As shown in Figure 2, upon the 
withdrawal of Rot, within 30 min the Rot-induced su-
peroxide decreased by ~40%, and the level was main-
tained for the next 7.5 hours. Removing MA from the 
medium reduced superoxide level by over 90% within 
30 min. Surprisingly, when AA and ST were removed, 
the superoxide levels decreased to about 50% at 3 h, 
but increased to 110-150% at 8 h.  
 
Figure 1. The increase of intracellular superoxide level in-
duced by inhibitors of the electron transport chain. The 
concentration HT22 cells were treated for 30 min with rotenone 
(0-2.5 µM), malonate (0-15 mM), antimycin A (0-40 µM) and 
stigmatellin (0-30 µM). DMSO treated cells were used as con-
trol. The intracellular superoxide level was indicated by the 
fluorescent intensity of oxidized hydroethidine. Average values 
and SD are shown, N=3.  
 
 
 
 
Figure 2. The change of intracellular superoxide level after 
withdrawal of the inhibitors of electron transport chain. 
HT22 cells were treated with rotenone (0.5 µM), malonate (5 
mM), antimycin A (20 µM) and stigmatellin (20 µM) for 30 
min, then washed and recovered in normal medium for up to 8 h. 
Average values and SD are shown, N=3.  
The responses of oxidative stress-related genes to 
Rotenone treatment 
 After treatment with 0.5 µM Rot or equal volume 
of DMSO for 16 h, the expression levels of selected 
genes were monitored by real-time PCR. Figure 3 
shows that the expression level of enzymes that di-
rectly scavenge ROS, such as SOD1, SOD2, GPx1, and 
catalase, decreased by 10-30%. On the other hand, 
phase II enzymes including GCS-HC, GCS-LC, GSTo1, 
GSTa2 and HO-1, were up regulated by 30-100%. Two 
selenoproteins, selenoprotein H and thioredoxin re-Int. J. Biol. Sci. 2007, 3 
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ductase 1 were upregulated by 30-50%. Using either 
HPRT1 or GAPDH as housekeeping gene for nor-
malization resulted in similar change. We also ob-
served that the onset of the change of expression of 
different genes differed, e.g. the expression of GCS-HC 
increased 2 folds at 4 h, but the increase of HO-1 
mRNA did not occur until 16 h. 
 
 
Figure 3. Effects of rotenone treatment on gene expression 
in HT22 cells. The gene expression level of superoxide dis-
mutase 1 and 2 (SOD1, SOD2), glutathione peroxide 1 (GPx1), 
catalase (Cat), glutamylcysteine synthetase heavy chain and 
light chain (GCS-HC, GCS-LC), glutathione s-transferase 
omega 1 and alpha 2 (GSTo1, GSTa2), heme oxygenase 1 
(HO-1), thioredoxin reductase 1 (TR1), and selenoprotein H 
(SelH) in HT22 cells after treatment with 0.5 µM rotenone for 
16 h. Average values and SD are shown. 
The protective effects of Se supplementation on the 
antioxidant status 
 The HT22 cells were supplemented with 100 nM 
sodium selenite for 24 h before challenge with 1.25 μM 
Rot for 30 min, then the total cellular GSH level and 
GPx activity were analyzed. As shown in Figure 4A, 
without Se supplementation, the total cellular GSH 
level (normalized to a protein concentration of 1 
mg/ml) decreased from 29.9 ± 0.9 µM to 24.4 ± 1.2 µM 
after the Rot treatment. Se supplementation signifi-
cantly increased the baseline of GSH level in the cells 
to 44.0 ± 1.0 µM, and abolished the Rot-induced GSH 
decrease. 
Figure 4B shows that in normal medium, similar 
activities of GPx (normalized to a protein concentra-
tion of 1 mg/ml) were observed in HT22 cells when 
treated with DMSO (2.3 ± 0.6 mU) and Rot (2.9 ± 0.2 
mU). However, Se supplementation rendered signifi-
cant increase in GPx activity under DMSO (33.1 ± 6.5 
mU) and Rot (26.4 ± 5.7 mU) treatments.  
Two-way ANOVA was also performed to ana-
lyze the influence of Se status and Rot treatment as 
independent factors and their combined effect. The 
result shows that for both GSH and GPx, the influence 
of Se status is significant (P<0.001), and the combina-
tion of Se status and Rot treatment also has significant 
influence on GSH level (P=0.0023). 
 
Figure 4. Effects of selenium supplementation and rotenone 
treatment on (A) total glutathione level and (B) glutathione 
peroxidase activity in HT22 cells. HT22 cells were incubated 
with medium containing 100 nM sodium selenite for 24 h, then 
treated by 1.25 µM rotenone for 30 min in normal medium. 
Average values and SD are shown, N=3. In Panel B, the statis-
tical comparisons are between Se Supplementation and normal 
medium after DMSO or Rot treatment. 
4.  Discussion 
HT22 cell line is vulnerable to glutathione (GSH) 
depletion [22], and is a sensitive model for monitoring 
cellular responses to oxidative stress. It has been 
shown that the primary ROS-generating site in ETC 
can be different in different types of cells [10-13]. Our 
study indicates complex I is the major superox-
ide-producing site in HT22 cells since Rot treatment 
induced the highest level of intracellular ROS in com-
parison to the treatments with other ETC-inhibitors. 
Rot treatment has been widely used on animals as 
in vivo models [18] and on neuronal cells as in vitro 
models to reveal the etiology of PD [23]. Rot treatment 
induces mitochondrial ROS prior to apoptotic events 
[24]. Our study shows that superoxide is highly in-
ducible by Rot in HT22 cells, in accordance with pre-
vious studies on mitochondria isolated from rat brain 
and human parahippocampal gyrus [25], and on su-
peroxide production by nonsynaptic brain submito-Int. J. Biol. Sci. 2007, 3 
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chondrial particles from seven mammalian species 
[26]. The dose response of HT22 cells to Rot treatment 
is similar to those reported for isolated mitochondria 
and HL-60 cells in culture [24]. 
Approximately half of the Rot-induced superox-
ide was readily removable within 30 min after the 
withdrawal of Rot, but the rest remained for up to 8 h. 
This result indicates that Rot may induce superoxide 
through different mechanisms, e.g. reversible and 
high-dosage-demanding, versus irreversible and/or 
low-dosage-demanding. A neurotoxicity study 
showed that a short exposure to Rot at high concen-
trations reduced the viability of both dopaminergic 
and non-dopaminergic neurons, while chronic treat-
ment with low-concentrations of Rot caused selective 
toxicity to dopaminergic neurons [27]. Considering the 
vulnerability of dopaminergic neurons in PD, the 
low-dosage-demanding Rot toxicity indicated in the 
present study may be more involved in the patho-
genesis. This consideration also questions the neuro-
logical safety of the potential therapeutic strategy of 
administration of Rot before myocardial ischemia oc-
curs to decrease damage to the myocardium [28, 29]. 
Complex II dysfunction has been related to neu-
rodegenerative diseases such as Huntington’s disease, 
as well as hypoxia-dependent generation of ROS in 
lungs [30]. In mice and rats, MA injection in the stria-
tum produced a significant reduction in cytochrome 
oxidase activity in the tissue [31]. MA affected rat brain 
mitochondrial function and neuronal survival, medi-
ated by ROS and mitochondrial permeability transi-
tion at a significantly lower level of respiratory inhibi-
tion in comparison to mitochondria isolated from liver 
and kidney [32]. The present study shows that super-
oxide is highly inducible by MA in neuronal HT22 
cells, but the induced superoxide is readily reversible 
upon malonate withdrawal.  
Stigmatellin blocks electron flow at the Qo site of 
complex III by binding to the heme b-566 domain of 
cytochrome b as well as to the iron-sulfur protein [8, 9]. 
Structural study of native complex III indicated that 
binding of stigmatellin to the reduced iron-sulfur pro-
tein at Qo center may be involved in the rate limiting 
reaction at this site [33]. Blockade of complex III by 
stigmatellin generates ROS through complex I by 
electron accumulation at this upstream complex [7]; at 
the same time, stigmatellin at higher concentrations 
also stimulates superoxide production by inhibiting 
complex I at the rotenone site [34]. Antimycin A inhib-
its reduction of ubiquinone and ubisemiquinone anion 
by cytochrome b heme-560 at Qi center [8], increasing 
the ROS generation from Qo center [7], which is re-
leased into the cytoplasm through an anion channel 
[30, 35, 36]. When mitochondria isolated from rat heart 
inhibited by antimycin A, a large amount of superox-
ide was produced [7, 37]. However, the present study 
showed only 20-30% of increase of superoxide genera-
tion in HT22 cells after antimycin A treatment at satu-
rating concentration. The different responses might be 
due to tissue specificity, which alters the ratios and 
activities of complexes in the respiratory chain in mi-
tochondrion [35]. The reason of the biphaseic response 
of the HT22 cells to the removal of inhibitors on com-
plex III (Figure 2) is unknown. 
Figure 3 indicates that the ability of direct scav-
enging Rot-induced ROS may be compromised in 
HT22 cells since the expression of the enzymes that 
dismutate superoxide (SOD1, SOD2) or reduce hy-
drogen peroxide (GPx1, catalase) was decreased fol-
lowing the Rot treatment. On the other hand, GCS-HC 
and GCS-LH, subunits of the rate-limiting enzyme in 
the GSH de novo synthesis pathway, was up-regulated 
by 30-100%. Other phase II enzymes such as GSTs, and 
HO-1 were also up-regulated, indicating the signifi-
cance of involvement of phase II enzymes in combat-
ing the oxidative stress.  
Se is thought to exert most of its biological effects 
through its incorporation into selenoproteins. Se status 
has been shown to modulate redox-regulated tran-
scription factors such as AP-1 and NF-kappaB [38, 39]. 
It has been found to affect the pathogenesis of PD in 
animal models. For example, Se supplementation was 
reported to ameliorate brain tissue damage in 
6-hydroxydopamine treated mice by sustaining the 
GSH level in the tissues and decreasing oxidative 
stress [19]. In this study we found in a cell culture 
model that Se supplementation increased the baseline 
level of total GSH concentration and prevented 
Rot-induced GSH depletion. We also found that the 
gene expression of 2 selenoproteins possessing im-
portant regulatory function [40] was upregulated by 
Rot treatment, indicating the possibility of existence of 
other pathways in Se-related protective effects.  
The GPx activity assay in this study measured the 
total activity of GPxs that use BHPx and GSH as sub-
strates. Out of the seven GPxs that have been identified 
to date, GPx7 and mouse GPx6 are non-selenoproteins, 
therefore they are not likely to be dramatically influ-
enced by Se supplementation. GPx2 (gastrointestinal 
GPx) and GPx5 (sperm nuclei GPx) have tissue specific 
localization, while the expression of GPx3 (extracellu-
lar GPx) was found to be extremely low in mouse brain 
[41]. Our unpublished data showed that GPx4 (phos-
pholipid hydroperoxide glutathione peroxidase) is 
highly expressed in HT22 cells, but its mRNA level 
was not significantly influenced by Se supplementa-
tion. On the other hand, the expression of GPx1 (cyto-
solic GPx) is highly responsive to Se status. Using 
BHPx as substrate, the activity obtained from GPx4 is 
only 10% of that contributed by GPx1 [42]. Therefore, 
the increased GPx activity after Se supplementation 
observed in this study is most likely attributable to 
GPx1, as potentially counteracts the downregulation of 
GPx1 expression by long-term Rot treatment. 
5.  Conclusion 
  This study indicates that complex I is the major 
ROS-generating site in HT22 cells. Rotenone treatment 
decreased the gene expression of enzymes directly 
scavenging ROS but increases that of phase II en-
zymes. Selenium supplementation increased glu-
tathione levels and GPx1 activity in HT22 cells, may Int. J. Biol. Sci. 2007, 3 
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have a protective role in rotenone-induced oxidative 
stress.  
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